查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301166

支架技术市场规模、份额和趋势分析报告：按类型、按疾病类型、按应用、按最终用途、按地区、细分市场趋势，2023-2030 年

Scaffold Technology Market Size, Share & Trends Analysis Report By Type (Hydrogels, Polymeric Scaffolds), By Disease Type (Cancer, Neurology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

脚手架技术市场增长和趋势

Grand View Research, Inc.最新报告显示，预计2023年至2030年全球脚手架技术市场规模将以13.87%的复合年增长率增长，2030年达到49.2亿美元。

3D细胞培养正在扩大其应用范围，因为它可以有效地模拟组织的体内生理状态，从而有效地表达致病的微环境因素。

此外，越来越多的研究集中在新型水凝胶的开发上，例如可注射水凝胶、自愈水凝胶、混合水凝胶和刺激响应水凝胶，预计将在未来几年创造新的创收机会。

此外，由于近年来再生医学和组织工程的显着进展，3D生物打印在器官和组织重建中的应用越来越多。3D生物打印技术是再生医学领域最有利可图的进步之一，对市场增长产生积极影响。

许多公司正在开髮用于组织再生的新型 3D 生物打印个性化支架。例如，2022 年 6 月，3D Systems 启动了与 United Therapeutics Corporation 的研究合作，开发新型 3D 打印器官技术。同样，纳米纤维支架由于其高表面积与体积比以及模仿天然细胞外基质纤维结构的能力而越来越受欢迎。这种支架为细胞附着和增殖提供了有利的微环境，预计将在预测期内促进其采用并推动市场增长。

此外，COVID-19疫情继续成为脚手架技术市场的积极催化剂。组织工程广泛用于了解病毒学和流行病学、开发体外模型系统以及寻找对抗传染病的有效治疗解决方案。例如，2021 年10 月发表在《Advanced Healthcare Materials Journal》上的一项研究证明了一种新冠肺炎(COVID-19) 候选疫苗的开发，该候选疫苗采用生物材料支架作为招募免疫细胞的位点，以发展适应性免疫。

脚手架技术市场报告亮点

  • 水凝胶领域已成为最具主导地位的细分市场，2022 年收入占比最大，为 41.69%。用于製造水凝胶的微加工技术的进步预计将推动该领域的发展。
  • 由于全球每年进行的肌肉骨骼手术数量不断增加，骨科、肌肉骨骼和脊柱领域在 2022 年占据了最高的市场份额，达到 52.98%。
  • 北美在脚手架技术行业占据主导地位，2022 年收入份额最大，为 40.44%。医疗保健支出的增加和对最新脚手架技术的科学认识的提高正在推动该区域市场的发展。
  • 干细胞治疗、再生医学和组织工程占据市场主导地位，2022年份额为66.45%。这种增长是由于越来越多地采用支架技术用于美容和重建手术、软组织肿瘤修復和其他应用。
  • 生物技术和製药机构细分市场占据主导地位，2022 年收入份额最大，为 46.51%。该细分市场的增长得益于这些公司在组织工程领域广泛应用支架技术。

目录

第一章 调查方法和范围

  • 市场细分和范围
  • 市场定义
    • 信息分析
    • 市场塑造和数据可视化
    • 验证和发布数据
  • 调查假设
  • 信息采购
    • 初步调查
  • 信息或数据分析
  • 市场形成和验证
  • 市场模式
  • 全球市场：计算复合年增长率
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 竞争格局的快照

第三章市场变量、趋势和范围

  • 市场谱系展望
    • 母公司市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动力分析
    • 市场约束因素分析
  • 行业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影响分析

第四章按类型划分的业务分析

  • 脚手架技术市场：类型变化分析
  • 水凝胶
    • 2018-2030 年水凝胶市场估计和预测（百万美元）
    • 伤口癒合
    • 3D生物打印
    • 免疫调节
  • 聚合物支架
    • 2018-2030 年聚合物支架市场估计和预测（百万美元）
  • 微图案表面微孔板
    • 2018-2030 年微图案表面微孔板市场估计和预测（百万美元）
  • 基于纳米纤维的支架
    • 2018-2030 年基于纳米纤维的脚手架市场估计和预测（百万美元）

第五章 疾病业务分析

  • 脚手架技术市场：疾病类型的变异分析
  • 骨科、肌肉骨骼系统、脊柱
    • 2018-2030 年骨科、肌肉骨骼和脊柱市场估计与预测（百万美元）
  • 癌症
    • 2018-2030 年癌症市场估计和预测（百万美元）
  • 皮肤和表皮
    • 2018-2030 年皮肤和外皮市场估计和预测（百万美元）
  • 牙科
    • 2018-2030 年牙科市场估计和预测（百万美元）
  • 心脏病学和血管学
    • 2018-2030 年心脏病学和血管市场估计和预测（百万美元）
  • 神经病学
    • 2018-2030 年神经病学市场估计和预测（百万美元）
  • 泌尿科
    • 2018-2030 年泌尿外科市场估计和预测（百万美元）
  • 消化内科、妇科
    • 2018-2030 年胃肠病学和妇科市场估计和预测（百万美元）
  • 其他
    • 2018-2030 年其他疾病类型的市场估计和预测（百万美元）

第六章 按应用分类的业务分析

  • 脚手架技术市场：应用变化分析
  • 干细胞治疗、再生医学、组织工程
    • 2018-2030年干细胞治疗、再生医学、组织工程市场估计和预测（百万美元）
  • 药物发现
    • 2018-2030 年药物发现市场估计和预测（百万美元）
  • 其他
    • 2018-2030 年其他应用市场估计和预测（百万美元）

第七章最终用途业务分析

  • 脚手架技术市场：最终用途变化分析
  • 生物技术和製药组织
    • 2018-2030 年生物技术和製药市场估计和预测（百万美元）
  • 研究和实验室
    • 2018-2030年研究机构市场预测及预测（百万美元）
  • 医院和诊断中心
    • 2018-2030 年医院和诊断中心市场估计和预测（百万美元）
  • 其他
    • 2018-2030 年其他最终用途市场估计和预测（百万美元）

第八章区域业务分析

  • 2022 年和 2030 年脚手架技术市场份额（按地区）
  • 北美
    • 北美脚手架技术市场，2018-2030（百万美元）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲脚手架技术市场，2018-2030（百万美元）
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太脚手架技术市场，2018-2030（百万美元）
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲脚手架技术市场，2018-2030（百万美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • MEA 脚手架技术市场，2018-2030 年（百万美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第9章 竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/名单
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson, And Company
    • 3D Biotek LLC
    • Molecular Matrix, Inc.
    • REPROCELL, Inc.
    • Xanofi
    • Tecan Trading AG
    • Matricel Gmbh
    • Pelobiotech
    • Corning Incorporated
    • Akron Biotech
    • 4titude
    • Nuvasive, Inc.
    • Avacta Life Sciences Limited
    • Medtronic
    • Allergan
    • Vericel Corporation
Product Code: GVR-4-68039-913-6

Scaffold Technology Market Growth & Trends

The global scaffold technology market size is expected to reach USD 4.92 billion by 2030, expanding at 13.87% CAGR from 2023 to 2030, according to a new study by Grand View Research, Inc. The application of 3D cell cultures is growing as they are efficient in mimicking the in-vivo physiological state of tissues for efficient representation of disease-causing microenvironmental factors.

Furthermore, increasing research focusing on the development of novel hydrogel types including injectable hydrogels, self-healing hydrogels, hybrid hydrogels, and stimuli-responsive hydrogels are expected to open new revenue generation opportunities in the coming years.

In addition, the significant advancements in regenerative medicine and tissue engineering in recent years have increased the adoption of 3D bioprinting for organ and tissue reconstruction procedures. The 3D bioprinting technique is one of the most lucrative advancements in the field of regenerative medicine which can positively affect market growth.

Numerous companies are developing new 3D bio-printed personalized scaffolds for tissue regeneration. For instance, in June 2022, 3D Systems entered a collaboration with United Therapeutics Corporation for the development of novel 3D-printed organ technologies. Similarly, nanofiber scaffolds are gaining traction due to their high surface area-to-volume ratio and their ability to mimic the fibrous structure of the natural extracellular matrix. Such scaffolds provide a suitable microenvironment for cell adhesion and proliferation, which is anticipated to boost their adoption and drive market growth during the forecast period.

Moreover, the COVID-19 pandemic remains a positive catalyst for the market for scaffold technology. Tissue engineering is extensively used for understanding virology and epidemiology, developing in-vitro model systems, and finding efficient therapeutic solutions for dealing with infection. For instance, a study published in the Advanced Healthcare Materials Journal in October 2021 demonstrated the development of a COVID-19 vaccine candidate that employs biomaterial scaffolds as recruitment sites for immune cells for the development of adaptive immunity.

Scaffold Technology Market Report Highlights

  • The hydrogels segment emerged as the most dominant segment and accounted for the largest revenue share of 41.69% in 2022. Technological advancements in the microfabrication techniques used for the creation of hydrogels are expected to fuel the segment growth
  • The orthopedics, musculoskeletal, and spine segment held the highest market share of 52.98% in 2022 due to the increasing number of musculoskeletal procedures performed annually worldwide
  • North America dominated the scaffold technology industry and accounted for the largest revenue share of 40.44% in 2022. Rising healthcare expenditure and increasing scientific awareness about the latest scaffold technologies are driving the regional market
  • The stem cell therapy, regenerative medicine, and tissue engineering segment dominated the market with a share of 66.45% in 2022. The growth is attributed to the growing adoption of scaffold technology for aesthetic and reconstruction surgeries, soft tissue tumor repair, and other applications
  • The biotechnology and pharmaceutical organizations segment dominated the market with the largest revenue share of 46.51% in 2022. The growth in the segment is due to the extensive application of scaffold technology by these organizations in tissue engineering fields

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information Or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand For 3D Cellular Models In Translational Research
      • 3.2.1.2. Increasing Demand For Body Reconstruction Procedures And Tissue Engineering
      • 3.2.1.3. Advancements In Scaffold Technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Introduction Of Scaffold-Free Technology For 3D Cell Culture
      • 3.2.2.2. Lack Of Consistency In Generated Results
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Scaffold Technology Market: Type Movement Analysis
  • 4.2. Hydrogels
    • 4.2.1. Hydrogels Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.2. Wound Healing
      • 4.2.2.1. Wound Healing Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.3. 3D Bioprinting
      • 4.2.3.1. 3D Bioprinting Market Estimates And Forecast 2018 To 2030 (USD Million)
    • 4.2.4. Immunomodulation
      • 4.2.4.1. Immunomodulation Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.3. Polymeric Scaffolds
    • 4.3.1. Polymeric Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.4. Micropatterned Surface Microplates
    • 4.4.1. Micropatterned Surface Microplates Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.5. Nanofiber Based Scaffolds
    • 4.5.1. Nanofiber-Based Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 5. Disease Type Business Analysis

  • 5.1. Scaffold Technology Market: Disease Type Movement Analysis
  • 5.2. Orthopedics, Musculoskeletal, & Spine
    • 5.2.1. Orthopedics, Musculoskeletal, & Spine Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.3. Cancer
    • 5.3.1. Cancer Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.4. Skin & Integumentary
    • 5.4.1. Skin & Integumentary Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.5. Dental
    • 5.5.1. Dental Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.6. Cardiology & Vascular
    • 5.6.1. Cardiology & Vascular Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.7. Neurology
    • 5.7.1. Neurology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.8. Urology
    • 5.8.1. Urology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.9. GI, Gynecology
    • 5.9.1. GI, Gynecology Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Other Disease Type Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Scaffold Technology Market: Application Movement Analysis
  • 6.2. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
    • 6.2.1. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 6.3. Drug Discovery
    • 6.3.1. Drug Discovery Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Other Applications Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Scaffold Technology Market: End-Use Movement Analysis
  • 7.2. Biotechnology And Pharmaceutical Organizations
    • 7.2.1. Biotechnology And Pharmaceutical Organizations Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.3. Research Laboratories And Institutes
    • 7.3.1. Research Laboratories And Institutes Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.4. Hospitals And Diagnostic Centers
    • 7.4.1. Hospitals And Diagnostic Centers Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Other End-Uses Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Scaffold Technology Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. North America Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. U.S. Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Canada Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. UK Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Germany Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. France Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Italy Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Spain Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Denmark Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Sweden Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Norway Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Japan Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Australia Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Thailand Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Brazil Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Mexico Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. South Africa Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Saudi Arabia Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Scaffold Technology Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Kuwait Scaffold Technology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Thermo Fisher Scientific, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Becton, Dickinson, And Company
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. 3D Biotek LLC
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Molecular Matrix, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. REPROCELL, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Xanofi
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Tecan Trading AG
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Matricel Gmbh
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Pelobiotech
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Corning Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Akron Biotech
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. 4titude
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Nuvasive, Inc.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Avacta Life Sciences Limited
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives
    • 9.4.16. Medtronic
      • 9.4.16.1. Company Overview
      • 9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.16.3. Product Benchmarking
      • 9.4.16.4. Strategic Initiatives
    • 9.4.17. Allergan
      • 9.4.17.1. Company Overview
      • 9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.17.3. Product Benchmarking
      • 9.4.17.4. Strategic Initiatives
    • 9.4.18. Vericel Corporation
      • 9.4.18.1. Company Overview
      • 9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.18.3. Product Benchmarking
      • 9.4.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 Global scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global scaffold technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 North America scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 North America scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 12 U.S. scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 13 U.S. scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 14 U.S. scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 17 Canada scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 18 Canada scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Europe scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 25 Germany scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 26 Germany scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 27 Germany scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 30 UK scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 31 UK scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 34 France scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 35 France scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 36 France scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 38 Italy scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 39 Italy scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 42 Spain scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 43 Spain scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 46 Denmark scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 47 Denmark scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 50 Sweden scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 51 Sweden scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 54 Norway scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 55 Norway scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 62 Japan scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 63 Japan scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 64 Japan scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 67 China scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 68 China scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 69 China scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 71 India scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 72 India scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 73 India scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Australia scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 75 Australia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 76 Australia scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Thailand scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 79 Thailand scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 80 Thailand scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Korea scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 84 South Korea scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 87 Latin America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Latin America scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Latin America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America scaffold technology market, by country, 2018 - 2030 (USD Million)
  • Table 91 Brazil scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 92 Brazil scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 93 Brazil scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 96 Mexico scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 97 Mexico scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 100 Argentina scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 101 Argentina scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 104 Middle East and Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 105 Middle East and Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 106 Middle East and Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Middle East and Africa scaffold technology market, by region, 2018 - 2030 (USD Million)
  • Table 108 South Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 109 South Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 110 South Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 117 UAE scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 118 UAE scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE scaffold technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait scaffold technology market, by type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait scaffold technology market, by disease type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait scaffold technology market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait scaffold technology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Scaffold technology market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Scaffold technology market: Type outlook and key takeaways
  • Fig. 15 Scaffold technology market: Type movement analysis
  • Fig. 16 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Wound healing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 3D bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Immunomodulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Scaffold technology market: Disease type outlook and key takeaways
  • Fig. 24 Scaffold technology market: Disease type movement analysis
  • Fig. 25 Orthopedics, musculoskeletal, & spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Skin & integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cardiology & vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Urology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 GI, gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Other disease types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Scaffold technology market: Application outlook and key takeaways
  • Fig. 35 Scaffold technology market: Application movement analysis
  • Fig. 36 Stem cell therapy, regenerative medicine, & tissue engineering market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Scaffold technology market: End-Use outlook and key takeaways
  • Fig. 40 Scaffold technology market: End-Use movement analysis
  • Fig. 41 Biotechnology and pharmaceutical organizations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hospitals and diagnostic center market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Global scaffold technology market: Regional outlook and key takeaways
  • Fig. 46 Global scaffold technology market: Regional movement analysis
  • Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)